Bios Capital Management, LP Lantern Pharma Inc. Transaction History
Bios Capital Management, LP
- $88.9 Billion
- Q3 2025
A detailed history of Bios Capital Management, LP transactions in Lantern Pharma Inc. stock. As of the latest transaction made, Bios Capital Management, LP holds 1,015,715 shares of LTRN stock, worth $3.52 Million. This represents 4.97% of its overall portfolio holdings.
Number of Shares
1,015,715
Previous 1,075,952
5.6%
Holding current value
$3.52 Million
Previous $3.4 Billion
29.95%
% of portfolio
4.97%
Previous 4.68%
Shares
3 transactions
Others Institutions Holding LTRN
# of Institutions
33Shares Held
2.26MCall Options Held
18.4KPut Options Held
0-
Vanguard Group Inc Valley Forge, PA384KShares$1.33 Million0.0% of portfolio
-
Cm Management, LLC225KShares$780,7500.92% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny100KShares$347,3470.0% of portfolio
-
Geode Capital Management, LLC Boston, MA92.1KShares$319,5210.0% of portfolio
-
Voss Capital, LLC Houston, TX50KShares$173,5000.01% of portfolio
About Lantern Pharma Inc.
- Ticker LTRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,830,900
- Market Cap $37.6M
- Description
- Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. Its advanced drug candidate is LP-100, which is in phase II clinical trials to treat metastatic, castration-resistant, and prostate cancer. The company also develops LP-30...